| Title | Evidence to implementation continuum for universal health coverage |
| Year | 2015 |
| Author | C. Lahariya and N. Menabde |
| DOI | 10.1016/S1473-3099(14)71090-4 |
| URL | http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(14)71090-4/abstract |
| Journal | The Lancet Infectious Diseases |
| Document Type | Journal Article |
| Document Availability | Full Text |
| Classification | Other complementary UHC initiatives |
| Abstract | Globally, more than 1 billion people are estimated to be infected with soil-transmitted helminthiasis, of whom 300 million end up with severe disabilities. Despite the availability of one-dose preventive chemotherapy as global practice to control soil-transmitted helminthiasis, the national prevalence of such infections in 2010 was in the range of 20–50%, and most of the burden was in Asia and sub-Saharan Africa. A key challenge to the control and elimination of these diseases is a shortage of broad-spectrum preventive chemotherapies, which is compounded by the low prioritisation of research for new therapeutics for neglected diseases; so much so that, until 2011, only 1% of all therapeutic products developed were for neglected diseases, even though the burden due to these diseases is much higher. |
